Emerging molecular targets for treatment of erectile dysfunction: Vascular and regenerative therapies on the horizon

Chemical Compounds

• Galanin 100%
• EC 3.1.4.* (Phosphoric Diester Hydrolase) Inhibitor 89%
• Drug Target 67%
• Heme 54%
• Safety 50%

Medicine & Life Sciences

• Erectile Dysfunction 63%
• Blood Vessels 34%
• Therapeutics 9%
• Galanin 6%
• Hedgehog Proteins 5%
• Phosphodiesterase Inhibitors 5%
• Heme Oxygenase-1 5%
• Peroxidase 4%
• Cell- and Tissue-Based Therapy 4%
• Epidemics 3%
• Publications 3%
• Observational Studies 3%
• Chronic Disease 3%
• Safety 2%
• In Vitro Techniques 1%
• Pharmaceutical Preparations 1%
• Population 1%